DUBLIN–(BUSINESS WIRE)–The “Bioanalytical
Testing Services Market Size, Share & Trends Analysis Report By Molecule
Type (Small Molecule, and Large Molecule), By Test Type (ADME, PK, PD,
Bioavailability, Bioequivalence), And Segment Forecasts, 2019 – 2026”
report has been added to ResearchAndMarkets.com’s
offering.
The global bioanalytical testing services market size is anticipated to
reach USD 4.83 billion by 2026. It is projected to register a CAGR of
7.5% during the forecast period.
The economic efficiency offered for outsourcing as compared to
conducting an in-house study is encouraging the outsourcing of these
services that is expected to boost the demand.
Innovation or new Molecule development is directly proportional to the
demand for testing services. Due to pricing concerns, competitive
pressures, and lead-time to market, companies are opting for outsourcing
of bioanalytical testing services. The growing focus on customized care
as well as on technological advancements are lowering the molecule
lifecycle, which has resulted into rapid development of new molecules.
Performance of the market players in the pharmaceutical analytical
testing domain is greatly influenced by the demand from end-user. Due to
the increasing awareness level, intense market efforts, government
initiatives, and improving accessibility; consumers, these days, are
more anxious about personal care, leading to higher consumption of
pharmaceutical products. The rising consumption is projected to drive
the bioanalytical testing services market over the forecast period.
Further key findings from the report suggest:
-
Small molecule bioanalytical testing services held a lucrative share
in 2018, attributed to the maximum generic and branded drug compounds
coming under this category. -
Bioavailability (BA) and bioequivalence (BE) studies led in 2018 owing
to the great adoption in generic drug manufacturing. Moreover,
emergence of biosimilars is anticipated to further propel the demand
for BA and BE over the forecast period. -
North America led the global bioanalytical testing services market in
2018, attributed to the fact that it is one of the top manufacturing
hubs for highly reliable, complex, and high-end pharmaceuticals. -
Asia Pacific is anticipated to register the fastest CAGR over the
forecast period, owing to rising investments from many developed
countries coupled with various amendments in clinical trials
evaluation standards according to the global platform. -
Some of the key players include PPD; ICON plc; Covance Inc.; LabCorp;
Charles River Laboratories International, Inc.; inVentiv Health; SGS
SA; Toxikon, Inc.; Intertek group; and Pace Analytical Services, LLC.
Collaborations. Service portfolio expansion and mergers and
acquisitions are the key strategic undertakings by these players.
Key Topics Covered
Chapter 1 Report Scope
1.1 Segment Market Scope
1.2 Regional
Scope
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information
or Data Analysis
2.3 Market Formulation & Validation
2.4
Region Wise Market Calculation
2.5 Model Details
2.6 List of
Secondary Sources
2.7 List of Primary Sources
2.8 List of
Abbreviations
Chapter 3 Objectives
Chapter 4 Executive Summary
4.1 Market Outlook
4.2 Segment
Outlook
4.3 Competitive Insights
Chapter 5 Bioanalytical Testing Services Market Variables, Trends & Scope
5.1
Market Lineage Outlook
5.2 Penetration & Growth Prospect Mapping
5.3
Product Pipeline Analysis, by Stage
5.4 User Perspective Analysis
5.5
List of Key End-users, by region / by product / by country
5.6
Regulatory Framework
5.7 Market Variable Analysis
5.8
Bioanalytical Testing Services Market Analysis Tools
Chapter 6 Bioanalytical Testing Services: Molecule Type Segment Analysis
6.1
Bioanalytical Testing Services Market: Definition & Scope
6.2
Bioanalytical Testing Services Market: Segment Dashboard
6.3
Bioanalytical Testing Services Market: Market Share Analysis, 2018 & 2026
6.4
Small Molecule
6.5 Large Molecule
Chapter 7 Bioanalytical Testing Services Market: Test Type Segment
Analysis
7.1 Bioanalytical Testing Services Market: Definition &
Scope
7.2 Bioanalytical Testing Services Market: Segment Dashboard
7.3
Bioanalytical Testing Services Market: Market Share Analysis, 2018 & 2026
7.4
Absorption, Distribution, Metabolism, Excretion (ADME) Testing
7.5
PK Testing
7.6 PD Testing
7.7 Bioavailability Testing
7.8
Bioequivalence Testing
7.9 Others Testing
Chapter 8 Bioanalytical Testing Services Market: Crisscross Matrix
8.1
Small Molecule
8.2 Large Molecule
Chapter 9 Bioanalytical Testing Services Market: Regional Analysis
9.1
Bioanalytical Testing Services Market: Definition & Scope
9.2
Regional Market Snapshot
9.3 Regional Market Share and Leading
Players, 2018
9.4 SWOT Analysis, by Factor (Political & Legal,
Economic and Technological)
9.5 Bioanalytical Testing Services
Market: Market Share Analysis, 2018 & 2026
9.6 North America
9.7
Europe
9.8 Latin America
9.9 MEA
Chapter 10 Competitive Analysis
10.1 Recent Developments & Impact
Analysis, By Key Market Participants
10.2 Company/Competition
Categorization (Key Innovators, Market Leaders, Emerging Players)
10.3
Vendor Landscape
10.4 Public Companies
10.5 Private Companies
10.6
Supplier Ranking
Chapter 11 Company Profiles
11.1 Strategic Framework
Chapter 12 KOL Commentary
Chapter 13 Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/3mcjdd
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology